| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Burns | 201 | 2024 | 1875 | 17.150 |
Why?
|
| Burn Units | 33 | 2024 | 143 | 4.200 |
Why?
|
| Frostbite | 4 | 2022 | 24 | 2.370 |
Why?
|
| Burns, Inhalation | 14 | 2020 | 35 | 1.790 |
Why?
|
| Fires | 5 | 2019 | 171 | 1.460 |
Why?
|
| Stevens-Johnson Syndrome | 10 | 2021 | 246 | 1.390 |
Why?
|
| Skin Transplantation | 20 | 2020 | 1091 | 1.380 |
Why?
|
| Resuscitation | 13 | 2018 | 672 | 1.280 |
Why?
|
| Smoke Inhalation Injury | 6 | 2016 | 47 | 1.260 |
Why?
|
| Multiple Trauma | 6 | 2014 | 370 | 1.060 |
Why?
|
| Military Medicine | 3 | 2018 | 184 | 0.950 |
Why?
|
| Child, Preschool | 103 | 2024 | 42225 | 0.950 |
Why?
|
| Wound Infection | 14 | 2017 | 244 | 0.930 |
Why?
|
| Wound Healing | 26 | 2021 | 2800 | 0.870 |
Why?
|
| Child | 131 | 2024 | 80154 | 0.870 |
Why?
|
| Respiratory Insufficiency | 8 | 2023 | 1232 | 0.810 |
Why?
|
| Infant | 84 | 2024 | 36170 | 0.800 |
Why?
|
| Hypothermia | 3 | 2014 | 188 | 0.760 |
Why?
|
| Skin, Artificial | 7 | 2009 | 89 | 0.760 |
Why?
|
| Body Image | 3 | 2021 | 639 | 0.730 |
Why?
|
| Burns, Electric | 5 | 2022 | 40 | 0.690 |
Why?
|
| Blast Injuries | 4 | 2018 | 322 | 0.660 |
Why?
|
| Catheterization, Central Venous | 6 | 2012 | 526 | 0.660 |
Why?
|
| Stress Disorders, Post-Traumatic | 11 | 2017 | 4575 | 0.640 |
Why?
|
| Hand Injuries | 4 | 2018 | 239 | 0.630 |
Why?
|
| Disaster Planning | 4 | 2017 | 557 | 0.620 |
Why?
|
| Length of Stay | 19 | 2024 | 6417 | 0.620 |
Why?
|
| Critical Care | 11 | 2018 | 2696 | 0.610 |
Why?
|
| Adolescent | 96 | 2024 | 88300 | 0.610 |
Why?
|
| Fluid Therapy | 11 | 2018 | 578 | 0.600 |
Why?
|
| Sepsis | 10 | 2023 | 2585 | 0.590 |
Why?
|
| Humans | 265 | 2024 | 761222 | 0.590 |
Why?
|
| Enteral Nutrition | 6 | 2010 | 794 | 0.570 |
Why?
|
| Blood Loss, Surgical | 4 | 2014 | 637 | 0.560 |
Why?
|
| Bicycling | 2 | 2012 | 177 | 0.550 |
Why?
|
| Accidents, Traffic | 4 | 2012 | 820 | 0.530 |
Why?
|
| Survivors | 9 | 2021 | 2369 | 0.510 |
Why?
|
| Anxiety | 10 | 2021 | 4569 | 0.510 |
Why?
|
| Consumer Health Information | 1 | 2018 | 215 | 0.500 |
Why?
|
| Basal Metabolism | 1 | 2016 | 161 | 0.500 |
Why?
|
| Ambulatory Care | 4 | 2021 | 2770 | 0.490 |
Why?
|
| Bacteremia | 6 | 2019 | 978 | 0.480 |
Why?
|
| Music Therapy | 2 | 2007 | 111 | 0.480 |
Why?
|
| Body Surface Area | 8 | 2018 | 197 | 0.460 |
Why?
|
| Male | 146 | 2024 | 360703 | 0.460 |
Why?
|
| Triage | 4 | 2017 | 985 | 0.450 |
Why?
|
| Cicatrix, Hypertrophic | 3 | 2008 | 80 | 0.450 |
Why?
|
| Bandages | 7 | 2021 | 269 | 0.450 |
Why?
|
| Stress Disorders, Traumatic, Acute | 4 | 2006 | 28 | 0.450 |
Why?
|
| Female | 148 | 2024 | 392552 | 0.430 |
Why?
|
| Parenteral Nutrition | 2 | 2013 | 659 | 0.410 |
Why?
|
| Comprehension | 1 | 2018 | 619 | 0.410 |
Why?
|
| Respiration, Artificial | 10 | 2023 | 2631 | 0.410 |
Why?
|
| Health Literacy | 1 | 2018 | 444 | 0.410 |
Why?
|
| Retrospective Studies | 66 | 2024 | 80675 | 0.400 |
Why?
|
| Biological Dressings | 4 | 2001 | 30 | 0.400 |
Why?
|
| Debridement | 7 | 2021 | 493 | 0.390 |
Why?
|
| Pain | 12 | 2020 | 5072 | 0.390 |
Why?
|
| Injury Severity Score | 14 | 2017 | 1046 | 0.390 |
Why?
|
| Referral and Consultation | 1 | 2024 | 3608 | 0.380 |
Why?
|
| Fever | 2 | 2019 | 1618 | 0.380 |
Why?
|
| Heat Stress Disorders | 1 | 2012 | 80 | 0.380 |
Why?
|
| Artificial Limbs | 1 | 2012 | 121 | 0.370 |
Why?
|
| Nitric Oxide | 4 | 2009 | 2137 | 0.360 |
Why?
|
| Contracture | 4 | 2020 | 235 | 0.360 |
Why?
|
| Hyperamylasemia | 1 | 2010 | 6 | 0.350 |
Why?
|
| Sertraline | 1 | 2011 | 209 | 0.350 |
Why?
|
| Gram-Negative Bacterial Infections | 2 | 2007 | 237 | 0.340 |
Why?
|
| Wounds, Penetrating | 2 | 2014 | 314 | 0.330 |
Why?
|
| Rewarming | 1 | 2009 | 64 | 0.330 |
Why?
|
| Femoral Vein | 3 | 2006 | 153 | 0.330 |
Why?
|
| Cross Infection | 8 | 2010 | 1422 | 0.320 |
Why?
|
| Muscle Proteins | 3 | 2021 | 1149 | 0.320 |
Why?
|
| Transplantation, Autologous | 8 | 2009 | 2112 | 0.320 |
Why?
|
| Midazolam | 3 | 2003 | 267 | 0.320 |
Why?
|
| Keratinocytes | 2 | 2004 | 790 | 0.310 |
Why?
|
| Laser Therapy | 4 | 2024 | 1094 | 0.310 |
Why?
|
| Alcoholic Intoxication | 1 | 2009 | 174 | 0.310 |
Why?
|
| Electric Injuries | 2 | 1999 | 24 | 0.310 |
Why?
|
| Language | 1 | 2018 | 1539 | 0.310 |
Why?
|
| Energy Metabolism | 4 | 2016 | 2877 | 0.310 |
Why?
|
| Lasers, Dye | 1 | 2008 | 28 | 0.310 |
Why?
|
| Skin | 7 | 2012 | 4473 | 0.300 |
Why?
|
| Emergency Medical Services | 3 | 2017 | 1920 | 0.300 |
Why?
|
| Lipase | 2 | 2010 | 320 | 0.300 |
Why?
|
| Foot Injuries | 1 | 2009 | 149 | 0.300 |
Why?
|
| Social Participation | 2 | 2021 | 184 | 0.300 |
Why?
|
| Conjunctivitis | 1 | 2009 | 155 | 0.300 |
Why?
|
| Morphine | 5 | 2009 | 656 | 0.290 |
Why?
|
| Soft Tissue Injuries | 3 | 2003 | 172 | 0.290 |
Why?
|
| Selenium | 1 | 2010 | 416 | 0.290 |
Why?
|
| Catheterization | 2 | 2012 | 1428 | 0.290 |
Why?
|
| Family Characteristics | 1 | 2012 | 992 | 0.290 |
Why?
|
| Trauma Severity Indices | 9 | 2018 | 478 | 0.280 |
Why?
|
| Nutritional Requirements | 3 | 2010 | 274 | 0.280 |
Why?
|
| Wounds, Nonpenetrating | 4 | 2007 | 808 | 0.280 |
Why?
|
| Colistin | 1 | 2007 | 44 | 0.280 |
Why?
|
| Burns, Chemical | 3 | 2018 | 123 | 0.280 |
Why?
|
| Epidermis | 4 | 2004 | 526 | 0.270 |
Why?
|
| Internet | 2 | 2018 | 3096 | 0.270 |
Why?
|
| General Surgery | 1 | 2018 | 1693 | 0.270 |
Why?
|
| Patient Care Team | 4 | 2005 | 2515 | 0.270 |
Why?
|
| Analgesics, Opioid | 6 | 2014 | 3805 | 0.270 |
Why?
|
| Ilium | 1 | 2007 | 154 | 0.270 |
Why?
|
| Cicatrix | 3 | 2024 | 793 | 0.260 |
Why?
|
| Disasters | 4 | 2017 | 520 | 0.260 |
Why?
|
| Intubation, Intratracheal | 4 | 2013 | 1331 | 0.260 |
Why?
|
| Pneumonia | 5 | 2013 | 2142 | 0.260 |
Why?
|
| Intubation | 2 | 2003 | 139 | 0.260 |
Why?
|
| Thrombolytic Therapy | 2 | 2017 | 2055 | 0.260 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 2 | 2007 | 585 | 0.240 |
Why?
|
| Surgical Procedures, Operative | 3 | 2014 | 1923 | 0.240 |
Why?
|
| Carbamazepine | 1 | 2005 | 224 | 0.240 |
Why?
|
| Military Personnel | 1 | 2014 | 1246 | 0.240 |
Why?
|
| Airway Obstruction | 2 | 2008 | 660 | 0.240 |
Why?
|
| Wound Closure Techniques | 2 | 2018 | 87 | 0.240 |
Why?
|
| Infant, Newborn | 18 | 2024 | 26200 | 0.230 |
Why?
|
| Multiple Organ Failure | 2 | 1998 | 386 | 0.230 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 3 | 2005 | 2270 | 0.230 |
Why?
|
| Time Factors | 22 | 2024 | 39957 | 0.230 |
Why?
|
| Child Behavior | 2 | 2007 | 848 | 0.230 |
Why?
|
| Proteins | 6 | 2019 | 5993 | 0.220 |
Why?
|
| Abdominal Injuries | 1 | 2007 | 361 | 0.220 |
Why?
|
| Electrosurgery | 1 | 2003 | 51 | 0.220 |
Why?
|
| Laryngeal Masks | 1 | 2004 | 102 | 0.220 |
Why?
|
| Acyclovir | 2 | 2002 | 267 | 0.220 |
Why?
|
| Nitrogen | 4 | 2016 | 345 | 0.220 |
Why?
|
| Lasers, Gas | 1 | 2024 | 101 | 0.220 |
Why?
|
| Adult | 70 | 2024 | 221120 | 0.210 |
Why?
|
| Neck | 1 | 2008 | 734 | 0.210 |
Why?
|
| Wounds and Injuries | 5 | 2010 | 2493 | 0.210 |
Why?
|
| Practice Guidelines as Topic | 7 | 2017 | 7400 | 0.210 |
Why?
|
| Functional Residual Capacity | 1 | 2002 | 70 | 0.210 |
Why?
|
| Hyperbaric Oxygenation | 2 | 2004 | 165 | 0.200 |
Why?
|
| Parents | 4 | 2021 | 3564 | 0.200 |
Why?
|
| Hospital Units | 1 | 2003 | 142 | 0.200 |
Why?
|
| Resilience, Psychological | 2 | 2021 | 788 | 0.200 |
Why?
|
| Terrorism | 1 | 2005 | 210 | 0.200 |
Why?
|
| Pediatrics | 6 | 2022 | 3590 | 0.200 |
Why?
|
| Growth Disorders | 1 | 2007 | 634 | 0.200 |
Why?
|
| Pentoxifylline | 1 | 2002 | 53 | 0.200 |
Why?
|
| Face | 1 | 2008 | 1025 | 0.200 |
Why?
|
| Emergency Medicine | 2 | 2005 | 1198 | 0.190 |
Why?
|
| Anti-Anxiety Agents | 3 | 2002 | 397 | 0.190 |
Why?
|
| Soft Tissue Infections | 3 | 2014 | 168 | 0.190 |
Why?
|
| Anti-Bacterial Agents | 11 | 2018 | 7407 | 0.190 |
Why?
|
| Plasma Substitutes | 1 | 2001 | 57 | 0.190 |
Why?
|
| Epidermolysis Bullosa | 2 | 2014 | 29 | 0.190 |
Why?
|
| Electricity | 2 | 2003 | 175 | 0.190 |
Why?
|
| Surgical Wound Infection | 3 | 2005 | 1530 | 0.190 |
Why?
|
| Cooking | 3 | 1999 | 309 | 0.190 |
Why?
|
| Hypoxia, Brain | 2 | 1999 | 139 | 0.190 |
Why?
|
| Bacterial Infections | 5 | 2016 | 1390 | 0.190 |
Why?
|
| Purpura | 3 | 1997 | 117 | 0.190 |
Why?
|
| Glutamine | 1 | 2004 | 574 | 0.190 |
Why?
|
| Anti-Infective Agents, Local | 2 | 2014 | 247 | 0.180 |
Why?
|
| Tissue and Organ Procurement | 3 | 1999 | 963 | 0.180 |
Why?
|
| United States | 23 | 2024 | 72341 | 0.180 |
Why?
|
| Respiratory Therapy | 2 | 2008 | 125 | 0.180 |
Why?
|
| Herpes Simplex | 2 | 2002 | 465 | 0.180 |
Why?
|
| Acute-Phase Proteins | 1 | 2002 | 250 | 0.180 |
Why?
|
| Indocyanine Green | 3 | 1999 | 234 | 0.180 |
Why?
|
| Arm Injuries | 1 | 2022 | 156 | 0.180 |
Why?
|
| Treatment Outcome | 30 | 2024 | 64681 | 0.180 |
Why?
|
| Patient Transfer | 3 | 2014 | 794 | 0.180 |
Why?
|
| Vital Signs | 1 | 2022 | 144 | 0.180 |
Why?
|
| Body Height | 1 | 2007 | 1566 | 0.180 |
Why?
|
| Anesthetics, Intravenous | 1 | 2003 | 394 | 0.180 |
Why?
|
| Calorimetry, Indirect | 3 | 2016 | 173 | 0.180 |
Why?
|
| Infusions, Intravenous | 5 | 2007 | 2217 | 0.180 |
Why?
|
| Forehead | 1 | 2020 | 75 | 0.180 |
Why?
|
| Specialties, Nursing | 1 | 2000 | 10 | 0.180 |
Why?
|
| Follow-Up Studies | 22 | 2019 | 39127 | 0.180 |
Why?
|
| Hepatic Veins | 1 | 2000 | 112 | 0.180 |
Why?
|
| Hospitals, Special | 2 | 2019 | 90 | 0.180 |
Why?
|
| Blood Component Transfusion | 1 | 2001 | 142 | 0.180 |
Why?
|
| Age Factors | 12 | 2020 | 18384 | 0.170 |
Why?
|
| Catheters, Indwelling | 2 | 2006 | 426 | 0.170 |
Why?
|
| Myoglobinuria | 1 | 1999 | 22 | 0.170 |
Why?
|
| Propranolol | 1 | 2001 | 490 | 0.170 |
Why?
|
| Coloring Agents | 3 | 1999 | 561 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2002 | 415 | 0.170 |
Why?
|
| Boston | 12 | 2020 | 9327 | 0.170 |
Why?
|
| Amnion | 1 | 2001 | 197 | 0.170 |
Why?
|
| Central Venous Pressure | 1 | 1999 | 79 | 0.170 |
Why?
|
| Oxandrolone | 1 | 2019 | 24 | 0.170 |
Why?
|
| Aftercare | 2 | 2022 | 913 | 0.170 |
Why?
|
| Heart Arrest | 4 | 2000 | 1513 | 0.160 |
Why?
|
| Catheter-Related Infections | 2 | 2013 | 273 | 0.160 |
Why?
|
| Heparin | 2 | 2009 | 1632 | 0.160 |
Why?
|
| Propane | 1 | 1999 | 12 | 0.160 |
Why?
|
| Staphylococcal Infections | 3 | 1999 | 1401 | 0.160 |
Why?
|
| Spleen | 3 | 2007 | 2290 | 0.160 |
Why?
|
| Enema | 1 | 1999 | 141 | 0.160 |
Why?
|
| Fibroblasts | 2 | 2013 | 4138 | 0.160 |
Why?
|
| Sutures | 1 | 2001 | 282 | 0.160 |
Why?
|
| Streptococcus pyogenes | 1 | 2001 | 292 | 0.160 |
Why?
|
| Thoracic Vertebrae | 1 | 2003 | 612 | 0.160 |
Why?
|
| Garlic | 1 | 2018 | 28 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 2 | 2018 | 637 | 0.160 |
Why?
|
| Liver | 3 | 2021 | 7512 | 0.160 |
Why?
|
| Albumins | 2 | 2001 | 575 | 0.160 |
Why?
|
| Epidermolysis Bullosa, Junctional | 1 | 1998 | 12 | 0.160 |
Why?
|
| Chickenpox | 1 | 1999 | 96 | 0.160 |
Why?
|
| Sex Distribution | 3 | 2019 | 2277 | 0.150 |
Why?
|
| Carbon Monoxide Poisoning | 4 | 2008 | 65 | 0.150 |
Why?
|
| Sequence Analysis | 1 | 2019 | 240 | 0.150 |
Why?
|
| Interpersonal Relations | 2 | 2019 | 1437 | 0.150 |
Why?
|
| Clinical Competence | 1 | 2014 | 4788 | 0.150 |
Why?
|
| Micronutrients | 1 | 2001 | 381 | 0.150 |
Why?
|
| Social Adjustment | 1 | 2021 | 632 | 0.150 |
Why?
|
| Adrenal Insufficiency | 2 | 2007 | 194 | 0.150 |
Why?
|
| Laryngostenosis | 1 | 2020 | 167 | 0.150 |
Why?
|
| Eyelids | 1 | 2020 | 278 | 0.150 |
Why?
|
| Penicillins | 1 | 2001 | 403 | 0.150 |
Why?
|
| Radiation Injuries | 2 | 2017 | 1191 | 0.150 |
Why?
|
| Positive-Pressure Respiration | 1 | 2002 | 638 | 0.150 |
Why?
|
| Tracheal Stenosis | 1 | 2020 | 228 | 0.150 |
Why?
|
| Age Distribution | 3 | 2019 | 2871 | 0.150 |
Why?
|
| Quality of Life | 9 | 2024 | 13367 | 0.150 |
Why?
|
| Postoperative Complications | 3 | 2019 | 15637 | 0.150 |
Why?
|
| Camping | 1 | 1997 | 13 | 0.150 |
Why?
|
| Streptococcal Infections | 2 | 2003 | 617 | 0.150 |
Why?
|
| Mass Casualty Incidents | 2 | 2017 | 179 | 0.150 |
Why?
|
| Physical Examination | 3 | 2018 | 1255 | 0.150 |
Why?
|
| Plasma | 1 | 2001 | 586 | 0.150 |
Why?
|
| Propofol | 1 | 2003 | 602 | 0.150 |
Why?
|
| Computers, Handheld | 1 | 2019 | 210 | 0.150 |
Why?
|
| Railroads | 1 | 1997 | 63 | 0.140 |
Why?
|
| Portoenterostomy, Hepatic | 1 | 2017 | 22 | 0.140 |
Why?
|
| Adrenergic beta-Antagonists | 2 | 2011 | 1241 | 0.140 |
Why?
|
| Prospective Studies | 20 | 2019 | 54437 | 0.140 |
Why?
|
| Explosions | 1 | 2018 | 107 | 0.140 |
Why?
|
| Rehabilitation | 1 | 2018 | 130 | 0.140 |
Why?
|
| Accident Prevention | 1 | 1997 | 76 | 0.140 |
Why?
|
| Tissue Banks | 1 | 1998 | 184 | 0.140 |
Why?
|
| Sequence Analysis, Protein | 1 | 2018 | 261 | 0.140 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2020 | 324 | 0.140 |
Why?
|
| Acute Disease | 10 | 2011 | 7226 | 0.140 |
Why?
|
| Creatinine | 2 | 2016 | 1897 | 0.140 |
Why?
|
| Search Engine | 1 | 2018 | 142 | 0.140 |
Why?
|
| Spinal Fractures | 1 | 2003 | 704 | 0.140 |
Why?
|
| Athletic Injuries | 1 | 2007 | 1216 | 0.140 |
Why?
|
| Biliary Atresia | 1 | 2017 | 88 | 0.140 |
Why?
|
| Ossification, Heterotopic | 1 | 2019 | 235 | 0.140 |
Why?
|
| Nitrogen Isotopes | 1 | 2016 | 84 | 0.140 |
Why?
|
| Anabolic Agents | 1 | 2019 | 256 | 0.140 |
Why?
|
| Body Weight | 2 | 2007 | 4618 | 0.130 |
Why?
|
| Petroleum | 1 | 1996 | 80 | 0.130 |
Why?
|
| Radiography | 4 | 2012 | 6974 | 0.130 |
Why?
|
| Facial Injuries | 1 | 2018 | 190 | 0.130 |
Why?
|
| Pain Measurement | 8 | 2009 | 3549 | 0.130 |
Why?
|
| Combined Modality Therapy | 5 | 2018 | 8519 | 0.130 |
Why?
|
| Water | 3 | 2016 | 1410 | 0.130 |
Why?
|
| Gastrostomy | 1 | 1999 | 323 | 0.130 |
Why?
|
| Compartment Syndromes | 2 | 1999 | 159 | 0.130 |
Why?
|
| Brain Death | 1 | 1999 | 357 | 0.130 |
Why?
|
| Intensive Care Units, Pediatric | 3 | 2011 | 1017 | 0.130 |
Why?
|
| Leg Injuries | 1 | 2018 | 179 | 0.130 |
Why?
|
| Epinephrine | 1 | 1999 | 791 | 0.130 |
Why?
|
| Hydrocarbons | 1 | 1996 | 105 | 0.130 |
Why?
|
| Erythrocyte Transfusion | 1 | 2001 | 569 | 0.130 |
Why?
|
| Bronchoscopy | 3 | 2020 | 909 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 1999 | 655 | 0.130 |
Why?
|
| Nod1 Signaling Adaptor Protein | 1 | 2015 | 12 | 0.130 |
Why?
|
| Hydrogels | 1 | 2021 | 720 | 0.130 |
Why?
|
| Epiglottis | 1 | 1996 | 81 | 0.130 |
Why?
|
| Monitoring, Physiologic | 2 | 2017 | 1780 | 0.130 |
Why?
|
| Feedback | 1 | 2019 | 790 | 0.130 |
Why?
|
| Nutritional Support | 3 | 2006 | 173 | 0.130 |
Why?
|
| Ammonia | 1 | 2016 | 243 | 0.130 |
Why?
|
| Inhalation | 1 | 1996 | 143 | 0.120 |
Why?
|
| Membranes, Artificial | 1 | 2017 | 366 | 0.120 |
Why?
|
| Administration, Inhalation | 3 | 2009 | 1159 | 0.120 |
Why?
|
| Software | 3 | 2019 | 4431 | 0.120 |
Why?
|
| Glycine | 2 | 2016 | 659 | 0.120 |
Why?
|
| Nod2 Signaling Adaptor Protein | 1 | 2015 | 86 | 0.120 |
Why?
|
| Hydrofluoric Acid | 1 | 1995 | 13 | 0.120 |
Why?
|
| Nutritional Status | 4 | 2010 | 1597 | 0.120 |
Why?
|
| Emergency Service, Hospital | 3 | 2019 | 7865 | 0.120 |
Why?
|
| Fungemia | 1 | 1995 | 57 | 0.120 |
Why?
|
| Vasodilator Agents | 1 | 1999 | 989 | 0.120 |
Why?
|
| Cardiopulmonary Resuscitation | 2 | 2000 | 991 | 0.120 |
Why?
|
| Cold Temperature | 1 | 1999 | 783 | 0.120 |
Why?
|
| Cholecystostomy | 1 | 1995 | 48 | 0.120 |
Why?
|
| Oropharynx | 1 | 1996 | 137 | 0.120 |
Why?
|
| Crush Syndrome | 1 | 2014 | 8 | 0.120 |
Why?
|
| Mafenide | 1 | 2014 | 3 | 0.120 |
Why?
|
| Self Concept | 1 | 2021 | 1046 | 0.120 |
Why?
|
| Accidents | 3 | 2007 | 165 | 0.120 |
Why?
|
| Pruritus | 2 | 2016 | 378 | 0.120 |
Why?
|
| Fractures, Bone | 1 | 2007 | 2046 | 0.120 |
Why?
|
| Decompression, Surgical | 2 | 2014 | 607 | 0.120 |
Why?
|
| Surgical Equipment | 1 | 1994 | 57 | 0.120 |
Why?
|
| Dental Plaque | 1 | 2015 | 209 | 0.120 |
Why?
|
| Protein Conformation | 3 | 2018 | 3933 | 0.120 |
Why?
|
| Benchmarking | 3 | 2016 | 1045 | 0.120 |
Why?
|
| Acinetobacter Infections | 1 | 2015 | 72 | 0.120 |
Why?
|
| Reading | 1 | 2018 | 531 | 0.120 |
Why?
|
| Afghanistan | 1 | 2014 | 77 | 0.120 |
Why?
|
| Germinal Center | 1 | 2017 | 380 | 0.120 |
Why?
|
| Accidental Falls | 2 | 2019 | 1068 | 0.120 |
Why?
|
| Computer Systems | 1 | 2016 | 470 | 0.110 |
Why?
|
| Cholecystitis | 1 | 1995 | 180 | 0.110 |
Why?
|
| Serum Albumin | 1 | 1997 | 674 | 0.110 |
Why?
|
| Intestines | 2 | 2007 | 1908 | 0.110 |
Why?
|
| Hypercapnia | 1 | 1995 | 259 | 0.110 |
Why?
|
| Thiophenes | 1 | 2018 | 569 | 0.110 |
Why?
|
| Accidents, Home | 3 | 1999 | 71 | 0.110 |
Why?
|
| Collagen | 4 | 2014 | 2635 | 0.110 |
Why?
|
| Lumbar Vertebrae | 1 | 2003 | 1876 | 0.110 |
Why?
|
| Analysis of Variance | 6 | 2010 | 6223 | 0.110 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 2002 | 1933 | 0.110 |
Why?
|
| Methicillin Resistance | 1 | 1994 | 198 | 0.110 |
Why?
|
| Flavobacterium | 1 | 1993 | 20 | 0.110 |
Why?
|
| Patient Satisfaction | 4 | 2024 | 3453 | 0.110 |
Why?
|
| Skin Diseases, Bacterial | 1 | 2014 | 67 | 0.110 |
Why?
|
| Emergency Treatment | 1 | 1997 | 495 | 0.110 |
Why?
|
| Stress, Psychological | 2 | 2007 | 4487 | 0.110 |
Why?
|
| Tracheostomy | 3 | 2020 | 426 | 0.110 |
Why?
|
| Nutrition Assessment | 2 | 2007 | 727 | 0.110 |
Why?
|
| Incidence | 13 | 2015 | 21366 | 0.110 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2017 | 199 | 0.110 |
Why?
|
| Acinetobacter baumannii | 1 | 2015 | 117 | 0.110 |
Why?
|
| Equipment Contamination | 1 | 1995 | 182 | 0.110 |
Why?
|
| Telephone | 1 | 2017 | 624 | 0.110 |
Why?
|
| Body Composition | 3 | 2016 | 2427 | 0.110 |
Why?
|
| Accidents, Occupational | 1 | 1995 | 249 | 0.110 |
Why?
|
| Skull | 1 | 1998 | 818 | 0.110 |
Why?
|
| Parenteral Nutrition Solutions | 1 | 2013 | 30 | 0.110 |
Why?
|
| Respiration | 1 | 2000 | 1657 | 0.110 |
Why?
|
| Specialization | 1 | 2018 | 778 | 0.110 |
Why?
|
| Middle Aged | 38 | 2024 | 220858 | 0.110 |
Why?
|
| Scrotum | 1 | 1993 | 116 | 0.110 |
Why?
|
| Survival Rate | 10 | 2017 | 12728 | 0.100 |
Why?
|
| Radiology, Interventional | 1 | 2017 | 477 | 0.100 |
Why?
|
| Logistic Models | 8 | 2017 | 13249 | 0.100 |
Why?
|
| Leukocyte Count | 1 | 2017 | 1597 | 0.100 |
Why?
|
| Water-Electrolyte Balance | 2 | 2005 | 325 | 0.100 |
Why?
|
| Baths | 1 | 1993 | 53 | 0.100 |
Why?
|
| Disinfection | 1 | 2015 | 207 | 0.100 |
Why?
|
| Afghan Campaign 2001- | 1 | 2014 | 298 | 0.100 |
Why?
|
| Candidiasis | 1 | 1995 | 365 | 0.100 |
Why?
|
| Employment | 1 | 2019 | 1114 | 0.100 |
Why?
|
| Massachusetts | 6 | 2018 | 8837 | 0.100 |
Why?
|
| Severity of Illness Index | 9 | 2017 | 15841 | 0.100 |
Why?
|
| Regeneration | 3 | 2014 | 1505 | 0.100 |
Why?
|
| Fibrinolytic Agents | 1 | 2002 | 2075 | 0.100 |
Why?
|
| Microscopy, Polarization | 1 | 2012 | 88 | 0.100 |
Why?
|
| Cause of Death | 2 | 2000 | 3688 | 0.100 |
Why?
|
| Patient Selection | 2 | 2005 | 4246 | 0.100 |
Why?
|
| Abdomen, Acute | 1 | 1992 | 122 | 0.100 |
Why?
|
| Diffusion of Innovation | 1 | 2017 | 730 | 0.100 |
Why?
|
| Critical Illness | 2 | 2023 | 2724 | 0.100 |
Why?
|
| Carbon Isotopes | 3 | 2004 | 458 | 0.100 |
Why?
|
| Electroporation | 1 | 2013 | 233 | 0.100 |
Why?
|
| Eosinophils | 1 | 2017 | 951 | 0.100 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2015 | 577 | 0.100 |
Why?
|
| Periodontal Diseases | 1 | 2015 | 450 | 0.100 |
Why?
|
| Antiviral Agents | 2 | 2002 | 3048 | 0.100 |
Why?
|
| Substance-Related Disorders | 2 | 2019 | 4413 | 0.100 |
Why?
|
| Oximetry | 1 | 1995 | 459 | 0.100 |
Why?
|
| Muscle, Skeletal | 2 | 2021 | 4947 | 0.100 |
Why?
|
| Child Development | 2 | 2021 | 2302 | 0.100 |
Why?
|
| Graft Survival | 5 | 2004 | 3843 | 0.100 |
Why?
|
| MicroRNAs | 4 | 2012 | 3758 | 0.100 |
Why?
|
| Perineum | 1 | 1993 | 208 | 0.090 |
Why?
|
| Trauma Centers | 3 | 2017 | 938 | 0.090 |
Why?
|
| Dietary Supplements | 1 | 2004 | 3410 | 0.090 |
Why?
|
| Nails, Malformed | 2 | 2002 | 34 | 0.090 |
Why?
|
| Feasibility Studies | 2 | 2019 | 5250 | 0.090 |
Why?
|
| Minocycline | 1 | 2012 | 169 | 0.090 |
Why?
|
| Immunization | 1 | 2015 | 1218 | 0.090 |
Why?
|
| Skin Diseases | 2 | 2002 | 1095 | 0.090 |
Why?
|
| Catheterization, Peripheral | 1 | 1994 | 343 | 0.090 |
Why?
|
| Social Support | 1 | 2021 | 2175 | 0.090 |
Why?
|
| Methylhistidines | 2 | 2010 | 35 | 0.090 |
Why?
|
| Case-Control Studies | 8 | 2022 | 22174 | 0.090 |
Why?
|
| Fibroblast Growth Factor 7 | 1 | 2010 | 59 | 0.090 |
Why?
|
| Leucine | 3 | 2004 | 546 | 0.090 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2854 | 0.090 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2014 | 6011 | 0.090 |
Why?
|
| Sickness Impact Profile | 3 | 2017 | 299 | 0.090 |
Why?
|
| Hospitals, Military | 1 | 1990 | 62 | 0.090 |
Why?
|
| Infection Control | 4 | 2005 | 983 | 0.090 |
Why?
|
| Aged, 80 and over | 16 | 2015 | 58952 | 0.090 |
Why?
|
| Rifampin | 1 | 2012 | 338 | 0.090 |
Why?
|
| Femoral Artery | 1 | 1994 | 826 | 0.090 |
Why?
|
| Disease Management | 2 | 2018 | 2507 | 0.090 |
Why?
|
| Posture | 1 | 1994 | 956 | 0.090 |
Why?
|
| Pancreatectomy | 1 | 1994 | 811 | 0.090 |
Why?
|
| Fatal Outcome | 4 | 2007 | 1838 | 0.090 |
Why?
|
| Pressure Ulcer | 2 | 2009 | 157 | 0.090 |
Why?
|
| Ventilator Weaning | 2 | 2009 | 164 | 0.080 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 194 | 0.080 |
Why?
|
| Registries | 2 | 2024 | 8246 | 0.080 |
Why?
|
| Equipment Design | 4 | 2012 | 3510 | 0.080 |
Why?
|
| Blood Pressure | 1 | 2005 | 8479 | 0.080 |
Why?
|
| Hallux | 1 | 2009 | 43 | 0.080 |
Why?
|
| Aged | 25 | 2019 | 169292 | 0.080 |
Why?
|
| Gallbladder Diseases | 1 | 1990 | 139 | 0.080 |
Why?
|
| Elastin | 1 | 2010 | 298 | 0.080 |
Why?
|
| Glutathione Peroxidase | 1 | 2010 | 258 | 0.080 |
Why?
|
| Biological Products | 1 | 2018 | 915 | 0.080 |
Why?
|
| Tocopherols | 1 | 2009 | 44 | 0.080 |
Why?
|
| Occupational Diseases | 1 | 1997 | 1490 | 0.080 |
Why?
|
| Endoscopy | 1 | 1999 | 1852 | 0.080 |
Why?
|
| Hand | 2 | 2009 | 902 | 0.080 |
Why?
|
| Cells, Cultured | 4 | 2009 | 18927 | 0.080 |
Why?
|
| Motor Skills Disorders | 2 | 2021 | 89 | 0.080 |
Why?
|
| Electric Stimulation Therapy | 1 | 2015 | 625 | 0.080 |
Why?
|
| Animals | 21 | 2021 | 168089 | 0.080 |
Why?
|
| Dexmedetomidine | 1 | 2013 | 317 | 0.080 |
Why?
|
| Ultrasonography, Interventional | 1 | 1997 | 1496 | 0.080 |
Why?
|
| Predictive Value of Tests | 4 | 2022 | 15308 | 0.080 |
Why?
|
| Liposarcoma | 1 | 2011 | 289 | 0.080 |
Why?
|
| Health Resources | 1 | 1995 | 934 | 0.080 |
Why?
|
| Risk Factors | 19 | 2019 | 74241 | 0.080 |
Why?
|
| Survival Analysis | 5 | 2002 | 10088 | 0.080 |
Why?
|
| Monitoring, Intraoperative | 1 | 1995 | 944 | 0.080 |
Why?
|
| Prognosis | 10 | 2022 | 29688 | 0.080 |
Why?
|
| Disease Susceptibility | 2 | 2005 | 1791 | 0.080 |
Why?
|
| Blood Volume | 2 | 1999 | 547 | 0.070 |
Why?
|
| Sex Factors | 2 | 2021 | 10553 | 0.070 |
Why?
|
| Biocompatible Materials | 3 | 2003 | 1683 | 0.070 |
Why?
|
| Splenic Rupture | 1 | 2007 | 26 | 0.070 |
Why?
|
| Young Adult | 10 | 2019 | 59222 | 0.070 |
Why?
|
| Pancreas | 1 | 1994 | 1684 | 0.070 |
Why?
|
| Antifungal Agents | 2 | 2008 | 752 | 0.070 |
Why?
|
| Hospital Mortality | 2 | 2000 | 5295 | 0.070 |
Why?
|
| Child, Hospitalized | 2 | 2006 | 182 | 0.070 |
Why?
|
| Cohort Studies | 3 | 2019 | 41496 | 0.070 |
Why?
|
| Dietary Proteins | 2 | 2006 | 951 | 0.070 |
Why?
|
| Nursing Evaluation Research | 1 | 2007 | 25 | 0.070 |
Why?
|
| Adrenergic beta-Agonists | 1 | 2009 | 346 | 0.070 |
Why?
|
| Acute Kidney Injury | 1 | 1999 | 1923 | 0.070 |
Why?
|
| Endoribonucleases | 1 | 2008 | 227 | 0.070 |
Why?
|
| Brain Injuries | 2 | 2012 | 2054 | 0.070 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2011 | 1057 | 0.070 |
Why?
|
| Subclavian Vein | 1 | 2006 | 57 | 0.070 |
Why?
|
| Hypnotics and Sedatives | 2 | 2013 | 1178 | 0.070 |
Why?
|
| Kinetics | 4 | 2004 | 6312 | 0.070 |
Why?
|
| Databases, Factual | 3 | 2019 | 7965 | 0.070 |
Why?
|
| Water Supply | 1 | 2008 | 204 | 0.070 |
Why?
|
| Anthropometry | 2 | 2005 | 1338 | 0.070 |
Why?
|
| Staphylococcus aureus | 1 | 1994 | 1450 | 0.070 |
Why?
|
| Glucose | 1 | 1998 | 4342 | 0.070 |
Why?
|
| Food, Formulated | 1 | 2006 | 101 | 0.070 |
Why?
|
| Epidemics | 1 | 2012 | 512 | 0.070 |
Why?
|
| Prevalence | 3 | 2017 | 15721 | 0.070 |
Why?
|
| Traumatology | 1 | 2007 | 100 | 0.070 |
Why?
|
| Reference Values | 3 | 2012 | 4921 | 0.070 |
Why?
|
| Antibodies, Bacterial | 2 | 2002 | 1464 | 0.070 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2008 | 380 | 0.060 |
Why?
|
| Drug Administration Schedule | 2 | 2004 | 4851 | 0.060 |
Why?
|
| Smiling | 1 | 2006 | 72 | 0.060 |
Why?
|
| Prosthesis Design | 1 | 2012 | 2114 | 0.060 |
Why?
|
| Tomography, Optical Coherence | 2 | 2012 | 2923 | 0.060 |
Why?
|
| Lung Abscess | 1 | 2005 | 40 | 0.060 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2006 | 353 | 0.060 |
Why?
|
| United States Government Agencies | 1 | 2005 | 26 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2004 | 2227 | 0.060 |
Why?
|
| Hospitalization | 4 | 2020 | 10707 | 0.060 |
Why?
|
| Comorbidity | 2 | 2015 | 10516 | 0.060 |
Why?
|
| Jugular Veins | 1 | 2006 | 210 | 0.060 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 436 | 0.060 |
Why?
|
| Hypertension | 1 | 2005 | 8536 | 0.060 |
Why?
|
| Dermis | 2 | 2004 | 202 | 0.060 |
Why?
|
| Spinal Cord Injuries | 1 | 1992 | 924 | 0.060 |
Why?
|
| Biopsy | 1 | 2017 | 6781 | 0.060 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2005 | 85 | 0.060 |
Why?
|
| Thorax | 1 | 2008 | 555 | 0.060 |
Why?
|
| Wounds, Gunshot | 1 | 1990 | 582 | 0.060 |
Why?
|
| Mycoses | 1 | 2008 | 386 | 0.060 |
Why?
|
| Brain Abscess | 1 | 2005 | 120 | 0.060 |
Why?
|
| Sensitivity and Specificity | 5 | 2018 | 14675 | 0.060 |
Why?
|
| Patient Admission | 2 | 2010 | 1365 | 0.060 |
Why?
|
| Motor Skills | 2 | 2020 | 521 | 0.060 |
Why?
|
| Multiprotein Complexes | 1 | 2010 | 1112 | 0.060 |
Why?
|
| Angiography | 1 | 2009 | 1597 | 0.060 |
Why?
|
| Pneumonia, Aspiration | 1 | 2005 | 145 | 0.060 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1375 | 0.060 |
Why?
|
| Paresis | 1 | 2005 | 176 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2009 | 12976 | 0.060 |
Why?
|
| Carbon Dioxide | 2 | 1998 | 1147 | 0.060 |
Why?
|
| Water Pollutants, Chemical | 1 | 2008 | 359 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 1990 | 876 | 0.060 |
Why?
|
| Malnutrition | 1 | 2010 | 622 | 0.060 |
Why?
|
| Steroids | 1 | 2009 | 929 | 0.050 |
Why?
|
| Neutron Activation Analysis | 1 | 2003 | 35 | 0.050 |
Why?
|
| Bromides | 1 | 2003 | 21 | 0.050 |
Why?
|
| Inpatients | 1 | 2015 | 2545 | 0.050 |
Why?
|
| Pilot Projects | 4 | 2016 | 8642 | 0.050 |
Why?
|
| Sodium Compounds | 1 | 2003 | 35 | 0.050 |
Why?
|
| Basement Membrane | 1 | 2004 | 348 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2014 | 8998 | 0.050 |
Why?
|
| Viscera | 1 | 2003 | 138 | 0.050 |
Why?
|
| Patient Isolators | 1 | 2002 | 11 | 0.050 |
Why?
|
| Music | 1 | 2006 | 245 | 0.050 |
Why?
|
| Systole | 1 | 2005 | 936 | 0.050 |
Why?
|
| Swine | 4 | 2021 | 5909 | 0.050 |
Why?
|
| Environment, Controlled | 1 | 2002 | 42 | 0.050 |
Why?
|
| Interview, Psychological | 1 | 2006 | 809 | 0.050 |
Why?
|
| Diastole | 1 | 2005 | 782 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 1995 | 3671 | 0.050 |
Why?
|
| Laryngoscopy | 2 | 2020 | 707 | 0.050 |
Why?
|
| Hemodynamics | 1 | 2013 | 4165 | 0.050 |
Why?
|
| Health Education | 2 | 2003 | 1049 | 0.050 |
Why?
|
| Surgery Department, Hospital | 1 | 2004 | 176 | 0.050 |
Why?
|
| Eye Injuries | 1 | 2005 | 227 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2013 | 1935 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10756 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2005 | 20588 | 0.050 |
Why?
|
| Patient Discharge | 2 | 2022 | 3441 | 0.050 |
Why?
|
| Quality Improvement | 1 | 2017 | 3808 | 0.050 |
Why?
|
| Facial Dermatoses | 1 | 2002 | 86 | 0.050 |
Why?
|
| Lung | 4 | 2005 | 9979 | 0.050 |
Why?
|
| Sequence Alignment | 2 | 2019 | 2175 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 1992 | 1278 | 0.050 |
Why?
|
| Thoracic Surgery | 1 | 2008 | 722 | 0.050 |
Why?
|
| Insurance, Health | 1 | 2013 | 2493 | 0.050 |
Why?
|
| Speech | 1 | 2006 | 554 | 0.050 |
Why?
|
| Electrodes | 1 | 2003 | 611 | 0.050 |
Why?
|
| Adolescent Behavior | 1 | 2009 | 1188 | 0.050 |
Why?
|
| Colloids | 1 | 2001 | 123 | 0.050 |
Why?
|
| Immunocompromised Host | 2 | 1999 | 858 | 0.050 |
Why?
|
| Pulmonary Edema | 1 | 2004 | 408 | 0.050 |
Why?
|
| Urban Health | 1 | 2003 | 532 | 0.050 |
Why?
|
| Social Behavior | 2 | 2020 | 1136 | 0.050 |
Why?
|
| Antioxidants | 1 | 2009 | 1667 | 0.050 |
Why?
|
| Risk Assessment | 6 | 2017 | 24022 | 0.040 |
Why?
|
| Ectropion | 1 | 2020 | 27 | 0.040 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1498 | 0.040 |
Why?
|
| Botulinum Toxins | 1 | 2002 | 189 | 0.040 |
Why?
|
| History, 20th Century | 2 | 1999 | 2765 | 0.040 |
Why?
|
| Hospital Departments | 2 | 2011 | 134 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 1998 | 1662 | 0.040 |
Why?
|
| Tissue Adhesions | 1 | 2021 | 218 | 0.040 |
Why?
|
| Virus Activation | 1 | 2002 | 319 | 0.040 |
Why?
|
| Radiography, Abdominal | 1 | 2003 | 534 | 0.040 |
Why?
|
| Coculture Techniques | 1 | 2004 | 1334 | 0.040 |
Why?
|
| Fracture Fixation | 1 | 2002 | 366 | 0.040 |
Why?
|
| Blepharoplasty | 1 | 2020 | 61 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2007 | 1330 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 5333 | 0.040 |
Why?
|
| Decompression Sickness | 1 | 1999 | 16 | 0.040 |
Why?
|
| Carboxyhemoglobin | 1 | 1999 | 83 | 0.040 |
Why?
|
| Education, Nursing, Continuing | 1 | 2000 | 69 | 0.040 |
Why?
|
| Exercise | 1 | 2016 | 5874 | 0.040 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2005 | 619 | 0.040 |
Why?
|
| Neuromuscular Blockade | 1 | 2001 | 147 | 0.040 |
Why?
|
| Nursing Assessment | 1 | 2000 | 106 | 0.040 |
Why?
|
| Partial Pressure | 1 | 1999 | 245 | 0.040 |
Why?
|
| Larva | 1 | 2021 | 511 | 0.040 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 14610 | 0.040 |
Why?
|
| Neuralgia | 1 | 2006 | 612 | 0.040 |
Why?
|
| Pharmaceutical Preparations | 1 | 2008 | 1086 | 0.040 |
Why?
|
| Cost of Illness | 2 | 2019 | 1936 | 0.040 |
Why?
|
| Chickenpox Vaccine | 1 | 1999 | 40 | 0.040 |
Why?
|
| History, 17th Century | 1 | 1999 | 108 | 0.040 |
Why?
|
| Blood Transfusion | 1 | 2006 | 1303 | 0.040 |
Why?
|
| Transplantation, Homologous | 2 | 1998 | 4822 | 0.040 |
Why?
|
| Device Approval | 1 | 2001 | 163 | 0.040 |
Why?
|
| Virus Replication | 1 | 2007 | 2426 | 0.040 |
Why?
|
| Health Status | 1 | 2012 | 4077 | 0.040 |
Why?
|
| Molecular Structure | 2 | 2018 | 1875 | 0.040 |
Why?
|
| Sheep | 1 | 2002 | 1436 | 0.040 |
Why?
|
| Birefringence | 2 | 2012 | 54 | 0.040 |
Why?
|
| Pigmentation Disorders | 1 | 1999 | 104 | 0.040 |
Why?
|
| Nanoparticles | 1 | 2010 | 1959 | 0.040 |
Why?
|
| Shock | 1 | 2001 | 314 | 0.040 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2012 | 8531 | 0.040 |
Why?
|
| Human Growth Hormone | 1 | 2004 | 642 | 0.040 |
Why?
|
| Hemostatic Techniques | 1 | 1999 | 111 | 0.040 |
Why?
|
| Patient Isolation | 1 | 1999 | 100 | 0.040 |
Why?
|
| Probability | 2 | 2001 | 2478 | 0.040 |
Why?
|
| Diet | 1 | 2016 | 8048 | 0.040 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2002 | 238 | 0.040 |
Why?
|
| Hematocrit | 1 | 1999 | 623 | 0.040 |
Why?
|
| Herpesvirus 3, Human | 1 | 1999 | 159 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2007 | 1545 | 0.040 |
Why?
|
| Craniocerebral Trauma | 1 | 2002 | 491 | 0.040 |
Why?
|
| Serum Globulins | 1 | 1997 | 23 | 0.040 |
Why?
|
| Intensive Care Units | 2 | 2012 | 3744 | 0.040 |
Why?
|
| Respiratory Mechanics | 1 | 2002 | 698 | 0.040 |
Why?
|
| Intubation, Gastrointestinal | 1 | 1999 | 165 | 0.040 |
Why?
|
| Urea | 2 | 1997 | 442 | 0.040 |
Why?
|
| Work | 1 | 2019 | 195 | 0.040 |
Why?
|
| Analgesics | 2 | 2011 | 1068 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2004 | 3606 | 0.040 |
Why?
|
| Household Articles | 1 | 1997 | 21 | 0.040 |
Why?
|
| Diaphragm | 1 | 1999 | 351 | 0.040 |
Why?
|
| Silver Nitrate | 1 | 1997 | 13 | 0.040 |
Why?
|
| Tissue Preservation | 1 | 1998 | 174 | 0.040 |
Why?
|
| Double-Blind Method | 1 | 2011 | 12341 | 0.040 |
Why?
|
| Ventilation-Perfusion Ratio | 1 | 1997 | 117 | 0.040 |
Why?
|
| Recovery of Function | 2 | 2020 | 2981 | 0.030 |
Why?
|
| Upper Extremity | 1 | 2022 | 658 | 0.030 |
Why?
|
| Fluorescence | 2 | 1999 | 751 | 0.030 |
Why?
|
| Clothing | 1 | 1997 | 96 | 0.030 |
Why?
|
| Breath Tests | 1 | 1998 | 299 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2004 | 6504 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2021 | 8164 | 0.030 |
Why?
|
| Cell Communication | 1 | 2004 | 1651 | 0.030 |
Why?
|
| Radiography, Thoracic | 1 | 2003 | 1302 | 0.030 |
Why?
|
| Venous Thrombosis | 1 | 2006 | 1304 | 0.030 |
Why?
|
| History, 19th Century | 1 | 1999 | 718 | 0.030 |
Why?
|
| Drug Interactions | 1 | 2001 | 1417 | 0.030 |
Why?
|
| Euphoria | 1 | 1996 | 65 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 739 | 0.030 |
Why?
|
| Cell Division | 1 | 2004 | 4451 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2004 | 1405 | 0.030 |
Why?
|
| Keratitis | 1 | 1999 | 240 | 0.030 |
Why?
|
| Protein C Deficiency | 1 | 1996 | 25 | 0.030 |
Why?
|
| Equipment Safety | 1 | 1997 | 249 | 0.030 |
Why?
|
| Organizational Case Studies | 1 | 2017 | 301 | 0.030 |
Why?
|
| Eye Diseases | 1 | 2002 | 653 | 0.030 |
Why?
|
| Mice | 7 | 2019 | 81330 | 0.030 |
Why?
|
| Campylobacter rectus | 1 | 2015 | 5 | 0.030 |
Why?
|
| Porphyromonas | 1 | 2015 | 6 | 0.030 |
Why?
|
| Porphyromonas endodontalis | 1 | 2015 | 9 | 0.030 |
Why?
|
| Meningitis, Meningococcal | 1 | 1996 | 43 | 0.030 |
Why?
|
| Urinary Tract Infections | 2 | 1999 | 801 | 0.030 |
Why?
|
| Acidosis, Respiratory | 1 | 1995 | 37 | 0.030 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 1997 | 275 | 0.030 |
Why?
|
| Barotrauma | 1 | 1995 | 39 | 0.030 |
Why?
|
| Anticoagulants | 2 | 2009 | 4795 | 0.030 |
Why?
|
| Disease Models, Animal | 4 | 2021 | 18222 | 0.030 |
Why?
|
| Nystatin | 1 | 1995 | 22 | 0.030 |
Why?
|
| Suicide, Attempted | 2 | 1997 | 1402 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2005 | 2019 | 0.030 |
Why?
|
| Staphylococcal Scalded Skin Syndrome | 1 | 1995 | 3 | 0.030 |
Why?
|
| Models, Statistical | 2 | 2011 | 5081 | 0.030 |
Why?
|
| Shock, Traumatic | 1 | 1995 | 22 | 0.030 |
Why?
|
| Regression Analysis | 3 | 2015 | 6345 | 0.030 |
Why?
|
| Laparotomy | 1 | 1997 | 456 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2012 | 7851 | 0.030 |
Why?
|
| Ovarian Neoplasms | 1 | 2012 | 4872 | 0.030 |
Why?
|
| Safety | 1 | 1999 | 1151 | 0.030 |
Why?
|
| Perception | 1 | 2021 | 1198 | 0.030 |
Why?
|
| Life Tables | 1 | 1995 | 364 | 0.030 |
Why?
|
| Research Design | 2 | 2009 | 6180 | 0.030 |
Why?
|
| Porphyromonas gingivalis | 1 | 2015 | 164 | 0.030 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2018 | 1535 | 0.030 |
Why?
|
| Rats | 3 | 2021 | 23705 | 0.030 |
Why?
|
| Language Development Disorders | 1 | 2016 | 193 | 0.030 |
Why?
|
| Crohn Disease | 1 | 1987 | 2278 | 0.030 |
Why?
|
| Prone Position | 1 | 1995 | 196 | 0.030 |
Why?
|
| Heart Rate | 1 | 2006 | 4197 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2015 | 150 | 0.030 |
Why?
|
| Haiti | 1 | 2016 | 549 | 0.030 |
Why?
|
| Culture Techniques | 1 | 1995 | 530 | 0.030 |
Why?
|
| Colony Count, Microbial | 1 | 1994 | 328 | 0.030 |
Why?
|
| Lifting | 1 | 1994 | 55 | 0.030 |
Why?
|
| Body Surface Potential Mapping | 1 | 2015 | 228 | 0.030 |
Why?
|
| Linear Models | 2 | 2015 | 5869 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2018 | 13402 | 0.030 |
Why?
|
| Child Abuse | 1 | 2002 | 1076 | 0.030 |
Why?
|
| Mutation | 1 | 2018 | 30004 | 0.030 |
Why?
|
| Edema | 1 | 1997 | 764 | 0.030 |
Why?
|
| Polyglycolic Acid | 1 | 1995 | 406 | 0.030 |
Why?
|
| Sanitary Engineering | 1 | 1993 | 3 | 0.030 |
Why?
|
| Evolution, Molecular | 2 | 2012 | 1882 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1995 | 1376 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2001 | 4015 | 0.030 |
Why?
|
| Computational Biology | 2 | 2018 | 3499 | 0.030 |
Why?
|
| Child Welfare | 1 | 1997 | 521 | 0.030 |
Why?
|
| Switzerland | 1 | 2013 | 319 | 0.030 |
Why?
|
| Models, Animal | 1 | 2019 | 2114 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2005 | 3923 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2017 | 1636 | 0.030 |
Why?
|
| Seizures | 1 | 2005 | 2965 | 0.030 |
Why?
|
| Fatigue | 1 | 2020 | 1550 | 0.030 |
Why?
|
| Cryopreservation | 1 | 1998 | 728 | 0.030 |
Why?
|
| Arginine | 1 | 1996 | 920 | 0.030 |
Why?
|
| Necrosis | 1 | 1997 | 1610 | 0.030 |
Why?
|
| Research | 1 | 2021 | 1976 | 0.030 |
Why?
|
| Blood-Borne Pathogens | 1 | 2012 | 52 | 0.030 |
Why?
|
| Chondroitin Sulfates | 2 | 2003 | 174 | 0.030 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 87 | 0.030 |
Why?
|
| Pregnancy | 1 | 2014 | 29893 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2017 | 20118 | 0.020 |
Why?
|
| Automation | 1 | 2014 | 585 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 2004 | 4420 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2015 | 26072 | 0.020 |
Why?
|
| Guidelines as Topic | 1 | 2018 | 1385 | 0.020 |
Why?
|
| Intraoperative Complications | 1 | 1999 | 1164 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2002 | 6304 | 0.020 |
Why?
|
| Administration, Topical | 1 | 1994 | 703 | 0.020 |
Why?
|
| Algorithms | 1 | 2012 | 14025 | 0.020 |
Why?
|
| Psychometrics | 2 | 2016 | 3061 | 0.020 |
Why?
|
| Extremities | 1 | 1997 | 867 | 0.020 |
Why?
|
| Benzodiazepines | 2 | 2011 | 1134 | 0.020 |
Why?
|
| Consensus | 1 | 2021 | 3134 | 0.020 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2189 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2015 | 583 | 0.020 |
Why?
|
| Entropy | 1 | 2011 | 210 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2013 | 880 | 0.020 |
Why?
|
| Rhodopsin | 1 | 2011 | 199 | 0.020 |
Why?
|
| Epithelium | 1 | 1996 | 1603 | 0.020 |
Why?
|
| Trypsin | 1 | 2011 | 486 | 0.020 |
Why?
|
| Biofilms | 1 | 2015 | 625 | 0.020 |
Why?
|
| Drug Monitoring | 1 | 1997 | 961 | 0.020 |
Why?
|
| Esophagus | 1 | 2017 | 1036 | 0.020 |
Why?
|
| Program Development | 1 | 2017 | 1294 | 0.020 |
Why?
|
| China | 1 | 2017 | 2374 | 0.020 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2011 | 91 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2003 | 4027 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 1994 | 767 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2002 | 4537 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2015 | 1186 | 0.020 |
Why?
|
| Neutralization Tests | 2 | 2002 | 725 | 0.020 |
Why?
|
| Coated Materials, Biocompatible | 1 | 2012 | 311 | 0.020 |
Why?
|
| Cholecystokinin | 1 | 1990 | 115 | 0.020 |
Why?
|
| Surgical Flaps | 1 | 1999 | 1670 | 0.020 |
Why?
|
| Cytokinesis | 1 | 2011 | 169 | 0.020 |
Why?
|
| Disabled Persons | 1 | 2000 | 1224 | 0.020 |
Why?
|
| Health Planning | 1 | 2011 | 231 | 0.020 |
Why?
|
| 3' Untranslated Regions | 1 | 2012 | 514 | 0.020 |
Why?
|
| Cell Line, Tumor | 3 | 2012 | 16954 | 0.020 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 915 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2011 | 702 | 0.020 |
Why?
|
| Emergencies | 1 | 1996 | 1217 | 0.020 |
Why?
|
| Energy Intake | 1 | 1997 | 2133 | 0.020 |
Why?
|
| RNA | 1 | 2019 | 2709 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 1216 | 0.020 |
Why?
|
| Transducers, Pressure | 1 | 2009 | 51 | 0.020 |
Why?
|
| Alcoholism | 1 | 2019 | 1973 | 0.020 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 696 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2016 | 1048 | 0.020 |
Why?
|
| Cell Count | 1 | 2013 | 1831 | 0.020 |
Why?
|
| Cost Savings | 1 | 2014 | 911 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 2012 | 1162 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3881 | 0.020 |
Why?
|
| Cyanides | 1 | 2008 | 82 | 0.020 |
Why?
|
| Adipogenesis | 1 | 2011 | 368 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2002 | 9187 | 0.020 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2012 | 4052 | 0.020 |
Why?
|
| Program Evaluation | 1 | 2017 | 2489 | 0.020 |
Why?
|
| Delaware | 1 | 2008 | 12 | 0.020 |
Why?
|
| Skin Abnormalities | 1 | 2008 | 60 | 0.020 |
Why?
|
| Pancreatitis | 1 | 1995 | 1081 | 0.020 |
Why?
|
| Pattern Recognition, Automated | 1 | 2014 | 993 | 0.020 |
Why?
|
| Water Pollution | 1 | 2008 | 30 | 0.020 |
Why?
|
| Waste Disposal, Fluid | 1 | 2008 | 33 | 0.020 |
Why?
|
| Forecasting | 2 | 1995 | 2928 | 0.020 |
Why?
|
| Cholecystectomy | 1 | 1990 | 404 | 0.020 |
Why?
|
| Shock, Septic | 1 | 1994 | 769 | 0.020 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2009 | 139 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 1997 | 1212 | 0.020 |
Why?
|
| Operating Rooms | 1 | 1994 | 790 | 0.020 |
Why?
|
| Oxygen | 1 | 1999 | 4228 | 0.020 |
Why?
|
| Disability Evaluation | 1 | 2015 | 1834 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 1990 | 365 | 0.020 |
Why?
|
| Brain | 2 | 2012 | 27094 | 0.020 |
Why?
|
| Aspergillus | 1 | 2008 | 94 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 4243 | 0.020 |
Why?
|
| Weight Gain | 1 | 1998 | 2349 | 0.020 |
Why?
|
| Health Surveys | 2 | 2008 | 4037 | 0.020 |
Why?
|
| Biomedical Engineering | 1 | 2009 | 286 | 0.020 |
Why?
|
| Reoperation | 1 | 1997 | 4303 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2015 | 14392 | 0.020 |
Why?
|
| Guideline Adherence | 1 | 1997 | 2220 | 0.020 |
Why?
|
| Ribonuclease III | 1 | 2008 | 267 | 0.020 |
Why?
|
| Candida | 1 | 2008 | 172 | 0.020 |
Why?
|
| Palliative Care | 1 | 2002 | 3599 | 0.020 |
Why?
|
| Population Surveillance | 1 | 1997 | 2598 | 0.020 |
Why?
|
| Drug Design | 1 | 2011 | 1044 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2013 | 10423 | 0.020 |
Why?
|
| Disease Progression | 2 | 2006 | 13511 | 0.020 |
Why?
|
| Light | 1 | 2012 | 1348 | 0.020 |
Why?
|
| Radionuclide Imaging | 1 | 1990 | 1989 | 0.020 |
Why?
|
| Monocytes | 1 | 2015 | 2570 | 0.020 |
Why?
|
| Temperature | 1 | 1993 | 2219 | 0.020 |
Why?
|
| Apoptosis | 2 | 2013 | 9478 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 1999 | 12052 | 0.020 |
Why?
|
| Anesthetics | 1 | 2011 | 523 | 0.020 |
Why?
|
| Viral Nonstructural Proteins | 1 | 2007 | 227 | 0.020 |
Why?
|
| Pressure | 1 | 2009 | 1155 | 0.020 |
Why?
|
| New York City | 1 | 2008 | 730 | 0.020 |
Why?
|
| Anxiety, Separation | 1 | 2005 | 86 | 0.020 |
Why?
|
| Aphasia, Broca | 1 | 2005 | 52 | 0.020 |
Why?
|
| Dexamethasone | 1 | 1993 | 1945 | 0.020 |
Why?
|
| Mental Health | 1 | 2000 | 3251 | 0.020 |
Why?
|
| Bacteria | 1 | 2016 | 2190 | 0.020 |
Why?
|
| Indonesia | 1 | 2005 | 128 | 0.020 |
Why?
|
| Empyema, Pleural | 1 | 2005 | 61 | 0.020 |
Why?
|
| Education, Medical, Continuing | 1 | 1990 | 825 | 0.020 |
Why?
|
| Anti-Infective Agents | 1 | 2012 | 983 | 0.010 |
Why?
|
| Deuterium | 1 | 2005 | 106 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1993 | 1818 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3778 | 0.010 |
Why?
|
| Protein Denaturation | 1 | 2004 | 241 | 0.010 |
Why?
|
| Base Sequence | 2 | 2007 | 12404 | 0.010 |
Why?
|
| Cost-Benefit Analysis | 1 | 1997 | 5493 | 0.010 |
Why?
|
| Mass Screening | 1 | 2019 | 5426 | 0.010 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 1995 | 2131 | 0.010 |
Why?
|
| Genome | 1 | 2011 | 1738 | 0.010 |
Why?
|
| Health Services Needs and Demand | 1 | 2011 | 1401 | 0.010 |
Why?
|
| Blotting, Western | 1 | 2010 | 5032 | 0.010 |
Why?
|
| DNA Copy Number Variations | 1 | 2012 | 2024 | 0.010 |
Why?
|
| Dissociative Disorders | 1 | 2005 | 234 | 0.010 |
Why?
|
| Firearms | 1 | 1990 | 626 | 0.010 |
Why?
|
| Breast | 1 | 2012 | 1964 | 0.010 |
Why?
|
| Inflammation | 1 | 2023 | 10759 | 0.010 |
Why?
|
| Cell Survival | 1 | 2013 | 5778 | 0.010 |
Why?
|
| Meningococcal Infections | 1 | 2003 | 77 | 0.010 |
Why?
|
| Socioeconomic Factors | 1 | 2017 | 7804 | 0.010 |
Why?
|
| Emotions | 1 | 2015 | 2742 | 0.010 |
Why?
|
| Rheumatic Heart Disease | 1 | 1984 | 163 | 0.010 |
Why?
|
| Fasciitis, Necrotizing | 1 | 2003 | 79 | 0.010 |
Why?
|
| Chi-Square Distribution | 1 | 2009 | 3418 | 0.010 |
Why?
|
| Reference Standards | 1 | 2006 | 1005 | 0.010 |
Why?
|
| Pericarditis | 1 | 1984 | 136 | 0.010 |
Why?
|
| Phrenic Nerve | 1 | 2002 | 79 | 0.010 |
Why?
|
| Health Status Indicators | 1 | 2008 | 970 | 0.010 |
Why?
|
| Clostridium botulinum | 1 | 2002 | 21 | 0.010 |
Why?
|
| Botulism | 1 | 2002 | 21 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2012 | 5406 | 0.010 |
Why?
|
| Stem Cells | 1 | 1995 | 3517 | 0.010 |
Why?
|
| Forearm | 1 | 2004 | 427 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2009 | 2697 | 0.010 |
Why?
|
| Seasons | 1 | 2008 | 1518 | 0.010 |
Why?
|
| Pneumothorax | 1 | 2005 | 386 | 0.010 |
Why?
|
| Glasgow Coma Scale | 1 | 2003 | 580 | 0.010 |
Why?
|
| Analgesia, Patient-Controlled | 1 | 2002 | 116 | 0.010 |
Why?
|
| Anesthetics, Dissociative | 1 | 2002 | 80 | 0.010 |
Why?
|
| APACHE | 1 | 2002 | 267 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2007 | 15521 | 0.010 |
Why?
|
| Environmental Monitoring | 1 | 2008 | 1460 | 0.010 |
Why?
|
| Pneumonia, Viral | 1 | 1999 | 3215 | 0.010 |
Why?
|
| Extracellular Space | 1 | 2003 | 563 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 2002 | 298 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2012 | 2223 | 0.010 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2002 | 419 | 0.010 |
Why?
|
| Tissue Expansion | 1 | 2002 | 160 | 0.010 |
Why?
|
| Canada | 1 | 2006 | 2125 | 0.010 |
Why?
|
| Peptide Library | 1 | 2002 | 347 | 0.010 |
Why?
|
| Caregivers | 1 | 1993 | 2244 | 0.010 |
Why?
|
| Models, Psychological | 1 | 2005 | 830 | 0.010 |
Why?
|
| Macrophages | 1 | 2015 | 5755 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 2002 | 1059 | 0.010 |
Why?
|
| Anisotropy | 1 | 2003 | 1284 | 0.010 |
Why?
|
| Life Change Events | 1 | 2005 | 952 | 0.010 |
Why?
|
| RNA-Binding Proteins | 1 | 2008 | 1855 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 3446 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2002 | 646 | 0.010 |
Why?
|
| Pulmonary Embolism | 1 | 1992 | 2571 | 0.010 |
Why?
|
| Cell Line | 1 | 2013 | 15545 | 0.010 |
Why?
|
| Saliva | 1 | 2003 | 828 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2007 | 3412 | 0.010 |
Why?
|
| Sample Size | 1 | 2001 | 843 | 0.010 |
Why?
|
| DNA Primers | 1 | 2002 | 2814 | 0.010 |
Why?
|
| Hot Temperature | 1 | 2004 | 1434 | 0.010 |
Why?
|
| Hospitals, General | 1 | 2002 | 799 | 0.010 |
Why?
|
| Medical Records | 1 | 2003 | 1409 | 0.010 |
Why?
|
| Dyspnea | 1 | 2005 | 1347 | 0.010 |
Why?
|
| Observer Variation | 1 | 2003 | 2610 | 0.010 |
Why?
|
| Least-Squares Analysis | 1 | 1997 | 368 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2011 | 6567 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 22128 | 0.010 |
Why?
|
| Bed Rest | 1 | 1996 | 83 | 0.010 |
Why?
|
| Environment Design | 1 | 1997 | 173 | 0.010 |
Why?
|
| Resuscitation Orders | 1 | 1998 | 270 | 0.010 |
Why?
|
| Visual Acuity | 1 | 2005 | 2676 | 0.010 |
Why?
|
| Amylases | 1 | 1995 | 171 | 0.010 |
Why?
|
| Parenteral Nutrition, Total | 1 | 1996 | 304 | 0.010 |
Why?
|
| Pancreatic Pseudocyst | 1 | 1995 | 111 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 1997 | 292 | 0.010 |
Why?
|
| Splenectomy | 1 | 1996 | 391 | 0.010 |
Why?
|
| Dobutamine | 1 | 1995 | 116 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2007 | 17598 | 0.010 |
Why?
|
| Catheterization, Swan-Ganz | 1 | 1995 | 86 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1997 | 2263 | 0.010 |
Why?
|
| Pancreatic Diseases | 1 | 1995 | 345 | 0.010 |
Why?
|
| Age of Onset | 1 | 2000 | 3307 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 6067 | 0.010 |
Why?
|
| Thrombocytopenia | 1 | 2000 | 1182 | 0.010 |
Why?
|
| Abscess | 1 | 1995 | 605 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2007 | 9417 | 0.010 |
Why?
|
| Echocardiography | 1 | 1984 | 5006 | 0.010 |
Why?
|
| Phenotype | 1 | 2008 | 16575 | 0.010 |
Why?
|
| Fasting | 1 | 1997 | 1603 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 2635 | 0.010 |
Why?
|
| Treatment Failure | 1 | 1996 | 2643 | 0.010 |
Why?
|
| Amino Acids | 1 | 1996 | 1703 | 0.010 |
Why?
|
| Antidepressive Agents | 1 | 2002 | 2893 | 0.010 |
Why?
|
| Shock, Cardiogenic | 1 | 1995 | 709 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 2002 | 3064 | 0.000 |
Why?
|
| Mortality | 1 | 1998 | 2896 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 36415 | 0.000 |
Why?
|